Bristol-Myers (BMY) Tops Q4 EPS by 5c; Issues In-Line FY13 EPS Outlook
Bristol-Myers Squibb Co. (NYSE: BMY) reported Q4 EPS of $0.47, $0.05 better than the analyst estimate of $0.42. Revenue for the quarter came in at $4.19 billion versus the consensus estimate of $4.14 billion.
Bristol-Myers Squibb Co. sees FY2013 EPS of $1.78-1.88, versus the consensus of $1.83.
For earnings history and earnings-related data on Bristol-Myers Squibb Co. (BMY) click here.
Bristol-Myers Squibb Co. sees FY2013 EPS of $1.78-1.88, versus the consensus of $1.83.
For earnings history and earnings-related data on Bristol-Myers Squibb Co. (BMY) click here.